Home NDC 11026-2650 Broncotron
Product NDC 11026-2650
11-digit product format 110262650
Labeler code 11026
Product ID 11026-2650_9146a6b6-cbaf-4304-b52f-6e6251b3f350
Type HUMAN OTC DRUG
Nonproprietary name Dextromethorphan HBr, Guaifenesin
Dosage form LIQUID
Route ORAL
Labeler Seyer Pharmatec, Inc.
Application part341
Marketing category OTC MONOGRAPH FINAL
Marketing start 2012-12-15
Marketing end 0000-00-00
Substance DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Active strength 20 mg/5mL; mg/5mL
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 30 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 11026-2650-4 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 11026-2650-4 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 11026-2650-4 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 11026-2650-4 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 11026-2650-4 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 11026-2650-4 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 11026-2650-4 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 11026-2650-4 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 11026-2650-4 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 11026-2650-4 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 11026-2650-4 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 11026-2650-4 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 11026-2650-4 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 11026-2650-4 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product I Inactivated by FDA 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 11026-2650-4 I Inactivated by FDA 110d247fa046…a55b01930146…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded DEXTROMETHORPHAN HYDROBROMIDE ACTIVE INGREDIENT 9D2RTI9KYH BRONCOTRON S (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [SEYER PHARMATEC, INC.] 2 GUAIFENESIN ACTIVE INGREDIENT 495W7451VQ BRONCOTRON S (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [SEYER PHARMATEC, INC.] 2 DEXTROMETHORPHAN ACTIVE MOIETY 7355X3ROTS BRONCOTRON S (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [SEYER PHARMATEC, INC.] 2 GUAIFENESIN ACTIVE MOIETY 495W7451VQ BRONCOTRON S (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [SEYER PHARMATEC, INC.] 2 AMMONIUM GLYCYRRHIZATE INACTIVE INGREDIENT 3VRD35U26C BRONCOTRON S (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [SEYER PHARMATEC, INC.] 2 CITRIC ACID MONOHYDRATE INACTIVE INGREDIENT 2968PHW8QP BRONCOTRON S (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [SEYER PHARMATEC, INC.] 2 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T BRONCOTRON S (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [SEYER PHARMATEC, INC.] 2 POTASSIUM CITRATE INACTIVE INGREDIENT EE90ONI6FF BRONCOTRON S (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [SEYER PHARMATEC, INC.] 2 POTASSIUM SORBATE INACTIVE INGREDIENT 1VPU26JZZ4 BRONCOTRON S (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [SEYER PHARMATEC, INC.] 2 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 BRONCOTRON S (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [SEYER PHARMATEC, INC.] 2 PROPYLPARABEN INACTIVE INGREDIENT Z8IX2SC1OH BRONCOTRON S (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [SEYER PHARMATEC, INC.] 2 SORBITOL INACTIVE INGREDIENT 506T60A25R BRONCOTRON S (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [SEYER PHARMATEC, INC.] 2 SUCRALOSE INACTIVE INGREDIENT 96K6UQ3ZD4 BRONCOTRON S (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [SEYER PHARMATEC, INC.] 2 WATER INACTIVE INGREDIENT 059QF0KO0R BRONCOTRON S (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [SEYER PHARMATEC, INC.] 2 XANTHAN GUM INACTIVE INGREDIENT TTV12P4NEE BRONCOTRON S (DEXTROMETHORPHAN HBR, GUAIFENESIN) LIQUID [SEYER PHARMATEC, INC.] 2